カテゴリー： IMARC, 世界, 医療/バイオ

アフェレシスの世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Apheresis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23AP133）◆商品コード：IMARC23AP133
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年3月2日
◆ページ数：148
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本調査資料によると、2022年に27億ドルであった世界のアフェレシス市場規模が、2028年までに43億ドルとなり、予測期間中にCAGR7.55%で拡大すると見込まれています。本書は、アフェレシスの世界市場を徹底的に分析し、市場の現状や今後の動向をまとめた資料です。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、コンポーネント別（血漿、血小板、白血球、リンパ球、赤血球）分析、製品別（装置、消耗品・試薬、ソフトウェア）分析、技術別（遠心分離、膜分離、選択的吸着）分析、処置別（ドナー・自動アフェレシス、治療用アフェレシス）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況など、以下の構成で掲載しています。また、本書内には、Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)、B. Braun SE、Charles River Laboratories International Inc.、Fresenius Medical Care AG & Co. KGaA、Haemonetics Corporation、Haier Biomedical、Kaneka Corporation、Medica S.p.a.、Miltenyi Biotec、Nikkiso Co. Ltd.、Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).など、参入企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のアフェレシス市場規模：コンポーネント別
- 血漿における市場規模
- 血小板における市場規模
- 白血球における市場規模
- リンパ球における市場規模
- 赤血球における市場規模
・世界のアフェレシス市場規模：製品別
- 装置の市場規模
- 消耗品・試薬の市場規模
- ソフトウェアの市場規模
・世界のアフェレシス市場規模：技術別
- 遠心分離における市場規模
- 膜分離における市場規模
- 選択的吸着における市場規模
・世界のアフェレシス市場規模：処置別
- ドナー・自動アフェレシスにおける市場規模
- 治療用アフェレシスにおける市場規模
・世界のアフェレシス市場規模：地域別
- 北米のアフェレシス市場規模
- アジア太平洋のアフェレシス市場規模
- ヨーロッパのアフェレシス市場規模
- 中南米のアフェレシス市場規模
- 中東・アフリカのアフェレシス市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

Market Overview:
The global apheresis market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.55% during 2023-2028.

Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

Apheresis Market Trends:
The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, product, technology, procedure, application and end user.

Breakup by Component:
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or Leukopheresis)
Lymphocytes (Lymphopheresis or Lymphapheresis)
RBC’s (Erythropheresis)

Breakup by Product:
Devices
Disposables and Reagents
Software

Breakup by Technology:
Centrifugation
Membrane Separation
Selective Adsorption

Breakup by Procedure:
Donor/Automated Apheresis
Therapeutic Apheresis

Breakup by Application:
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others

Breakup by End User:
Blood Centers
Hospitals
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), B. Braun SE, Charles River Laboratories International Inc., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Kaneka Corporation, Medica S.p.a., Miltenyi Biotec, Nikkiso Co. Ltd., Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).

Key Questions Answered in This Report:
How has the global apheresis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global apheresis market?
What are the key regional markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global apheresis market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Apheresis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Plasma (Plasmapheresis)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Platelets (Plateletpheresis)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Leukocytes (Leukapheresis or Leukopheresis)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 RBC’s (Erythropheresis)
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Product
7.1 Devices
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Disposables and Reagents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Technology
8.1 Centrifugation
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Membrane Separation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Selective Adsorption
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Procedure
9.1 Donor/Automated Apheresis
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Therapeutic Apheresis
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Application
10.1 Renal Disorders
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hematological Disorders
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Neurological Disorders
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Autoimmune Disorders
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by End User
11.1 Blood Centers
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Hospitals
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.2 B. Braun SE
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Charles River Laboratories International Inc.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 Financials
17.3.3.4 SWOT Analysis
17.3.4 Fresenius Medical Care AG & Co. KGaA
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 Haemonetics Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Haier Biomedical
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.7 Kaneka Corporation
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Medica S.p.a.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.9 Miltenyi Biotec
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.10 Nikkiso Co. Ltd.
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 Financials
17.3.10.4 SWOT Analysis
17.3.11 Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Bct Inc. (Terumo Corporation)
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アフェレシスの世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Apheresis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • バイオマーカーの世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • 生物製剤の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • 臨床栄養の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • タンパク質治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • スタチンの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆